Apolipoprotein E, B vitamins, and cognitive function in older adults

Journals of Gerontology - Series B Psychological Sciences and Social Sciences

Volumn 60, Issue 1, 2005, Pages

  Bunce, David ^a,b   Kivipelto, Miia ^b   Wahlin, Åke ^b,c  

^a UNIVERSITY OF LONDON   (United Kingdom)

^b STOCKHOLM GERONTOLOGY RESEARCH CENTER   (Sweden)

^c STOCKHOLM UNIVERSITY   (Sweden)

Author keywords

[No Author keywords available]

Indexed keywords

APOLIPOPROTEIN E; CYANOCOBALAMIN; VITAMIN B GROUP;

AGED; ALLELE; ARTICLE; COGNITION; DEMENTIA; DEPTH PERCEPTION; FEMALE; GENOTYPE; HUMAN; MAJOR CLINICAL STUDY; MALE; NEUROANATOMY; PRIORITY JOURNAL; RECOGNITION; SHORT TERM MEMORY; SKILL;

EID: 12344337313     PISSN: 10795014     EISSN: None     Source Type: Journal    
DOI: 10.1093/geronb/60.1.P41     Document Type: Article

References (51)

1. American Psychiatric Association. (1987). Diagnostic and statistical manual of mental disorders (3rd ed., rev.). Washington, DC: Author.
2. Anstey, K., & Christensen, H. (2000). Education, activity, health, blood pressure and apolipoprotein E as predictors of cognitive change in old age: A review. Gerontology, 46, 163-177.
3. Bäckman L., Wahlin, A., Small, B. J., Herlitz, A., Winblad, B., & Fratiglioni, L. (in press). Cognitive functioning in aging and dementia: The Kungsholmem Project. Aging, Neuropsychology and Cognition.
4. Barclay, L. L., Weiss, E. M., Mattis, S., Bond, O., & Blass, J. P. (1988). Unrecognized cognitive impairment in cardiac rehabilitation patients. Journal of the American Geriatrics Society, 36, 22-28.
5. Bondi, M. W., Salmon, D. P, Galasko, D., Thomas, R. G., & Thal, L. J. (1999). Neuropsychological function and apolipoprotein E genotype in the preclinical detection of Alzheimer's disease. Psychology and Aging, 14, 295-303.
6. Bookheimer, S. Y., Strojwas, M. H., Cohen, M. S., Saunders, A. M., Pericak-Vance, M. A., Mazziotta, J. C., et al. (2000). Patterns of brain activation in people at risk for Alzheimer's disease. The New England Journal of Medicine, 343, 450-456.
7. Borenstein Graves, A., Bowen, J. D., Rajaram, L., McCormick, W. C., McCurry, S. M., Schellenberg, & Larson, E. B. (1999). Impaired olfaction as a marker for cognitive decline. Neurology, 53, 1480-1487.
8. Bretsky, P., Guralnik, J. M., Launer, L., Albert, M., & Seeman, T. E. (2003). The role of APO-ε4 in longitudinal cognitive decline: MacArther studies of successful aging. Neurology, 60, 1077-1081.
9. Bunce, D., Fratiglioni, L., Small, B. J., Winblad, B., & Bäckman, L. (2004). APOE and cognitive decline in preclinical Alzheimer disease and non-demented aging. Neurology, 63, 816-821.
10. 12 or folate in adults aged 75 years and older. Neuropsychology, 18, 362-370.
11. Burggren, A. C., Small, G. W., Sabb, F. W., & Bookheimer, S. Y. (2002). Specificity of brain activation patterns in people at genetic risk for Alzheimer disease. American Journal of Geriatric Psychiatry, 10, 44-51.
12. Calvaresi, E., & Bryan, J. (2001). B vitamins, cognition, and aging: A review. Journal of Gerontology: Psychological Sciences, 56B, P327-P339.
13. 12 and folic acid in serum evaluated. Clinical Chemistry, 28, 2161-2165.
14. Cohen, R. M., Small, C., Lalonde, F., Friz, J., & Sunderland, T. (2001). Effects of apolipoprotein E genotype on hippocampal volume loss in aging healthy women. Neurology, 57, 2223-2228.
15. Cummings, J. L., Vinters, H. V., Cole, G. M., & Khachaturian, Z. S. (1998). Alzheimer's disease: Etiologies, pathophysiology, cognitive reserve, and treatment opportunities. Neurology, 51 (Suppl. 1), S2-S17.
16. Deary, I. J., Whalley, L. J., St. Clair, D., Breen, G., Leaper, S., Lemmon, H., et al. (2003). The influence of the e4 allele of the apolipoprotein E gene on childhood IQ, nonverbal reasoning in old age, and lifetime cognitive change. Intelligence, 31, 85-92.
17. Deary, I. J., Whiteman, M. C., Pattie, A., Starr, J. M., Hayward, C., Wright, A. F., et al. (2002). Cognitive change and the APOE e4 allele. Nature, 418, 932.
18. Ebly, E. M., Schaefer, J. P., Campbell, N. R. C., & Hogan, D. B. (1998). Folate status, vascular disease and cognition in elderly Canadians. Age and Ageing, 27, 485-491.
19. Farrer, L. A., Cupples, L. A., Haines, J. L., Hyman, B., Kukull, W. A., Mayeux, R., et al., for the APOE and Alzheimer Disease Meta Analysis Consortium. (1997). Effects of age, sex, and ethnicity on the association between apolipoprotein E genotype and Alzheimer disease: A meta-analysis. Journal of the American Medical Association, 278, 1349-1356.
20. Fillenbaum, G. G., Landerman, L. R., Blazer, D. G., Saunders, A. M., Harris, T. B., & Launer, L. J. (2001). The relationship of APOE genotype to cognitive functioning in older African-American and Caucasian community residents. Journal of the American Geriatric Society, 49, 1148-1155.
21. Fratiglioni, L., Viitanen, M., Bäckman, L., Sandman, P.-O., & Winblad, B. (1992). Occurrence of dementia in advanced age: The study design of the Kungsholmen Project. Neuroepidemiology, 11 (Suppl. 1), 29-36.
22. Haan, M. N., Shemanski, L., Jagust, W. J., Manolio, T. A., & Kuller, L. (1999). The role of APOE ε4 in modulating effects of other risk factors for cognitive decline in elderly persons. Journal of the American Medical Association, 282, 40-46.
23. 12 and folate status on episodic memory functioning: A population-based study of very old adults. Biological Psychiatry, 45, 1472-1480.
24. Hofer, S. M., Christensen, H., MacKinnon, A. J., Korten, A. E., Jorm, A. F., Henderson, A. S., et al. (2002). Changes in cognitive functioning associated with ApoE genotype in a community sample of older adults. Psychology and Aging, 17, 194-208.
25. Hyman, B. T., Gomez-Isla, T., Briggs, M., Chung, H., Nichols, S., Kohout, F., et al. (1996). Apolipoprotein E and cognitive change in an elderly population. Annals of Neurology, 40, 55-66.
26. Jonker, C., Schmand, B., Lindeboom, J., Havekes, L. M., & Launer, L. J. (1998). Association between apolipoprotein E e4 and the rate of cognitive decline in community-dwelling elderly individuals with and without dementia. Archives of Neurology, 55, 1065-1069.
27. Katzman, R. (1993). Education and the prevalence of dementia and Alzheimer's disease. Neurology, 43, 13-20.
28. Lange, K. L., Bondi, M. W., Salmon, D. P., Galasko, D., Delis, D. C., Thomas, R. G., et al. (2002). Decline in verbal memory during preclinical Alzheimer's disease: Examination of the effect of APOE genotype. Journal of the International Neuropsychological Society, 8, 943-955.
29. Lipinska, B., Bäckman, L., & Herlitz, A, (1992). When Greta Garbo is easier to remember than Stefen Edberg: Influences of prior knowledge on recognition memory in Alzheimer's disease. Psychology and Aging, 7, 214-220.
30. Martin, D. C., Francis, J., Protetch, J., & Huff, F. J. (1992). Time dependency of cognitive recovery with cobalamin replacement: Report of a pilot study. Journal of the American Geriatric Society, 40, 168-172.
31. Mayeux, R., Small, S. A., Tang, M.-X., Tycko, B., & Stern, Y. (2001). Memory performance in healthy elderly without Alzheimer's disease: Effects of time and apolipoprotein-E. Neurobiology of Aging, 22, 683-689.
32. 12 therapy: A longitudinal neuropsychological assessment. Neurology, 44, 1764-1765.
33. Moffat, S. D., Szekely, C. A., Zonderman, A. B., Kabani, N. J., & Resnick, S. M. (2000). Longitudinal change in hippocampal volume as a function of apolipoprotein E genotype. Neurology, 55, 134-136.
34. Mortensen, E. L., & Hogh, P. (2001). A gender differences in the association between APOE genotype and age-related cognitive decline. Neurology, 57, 89-95.
35. Mortimer, J. A. (1988). Do psychosocial risk factors contribute to Alzheimer's disease? In A. S. Henderson & J. H. Henderson (Eds.), Etiology of dementia in Alzheimer's disease (pp. 39-52). New York: Wiley.
36. Nilsson, L.-G., Nyberg, L., & Bäckman, L. (2002). Genetic variation in memory function. Neuroscience and Biobehavioral Reviews, 26, 841-848.
37. Pendleton, N., Payton, A., van den Boogerd, E. H., Holland, F., Diggle, P., Rabbitt, P. M. A., et al. (2002). Apolipoprotein E genotype does not predict decline in intelligence in healthy older adults. Neuroscience Letters, 324, 74-76.
38. Plassman, B. L., Welsh-Bohmer, K. A., Bigler, E. D., Johnson, S. C., Anderson, C. V., Helms, M. J., et al. (1997). Apolipoprotein E e4 allele and hippocampal volume in twins with normal cognition. Neurology, 48, 985-989.
39. Reiman, E. M., Caselli, R. J., Yun, L. S., Chen, K., Bandy, D., Minoshima, S., et al. (1996). Preclinical evidence of Alzheimer's disease in person homozygous for the e4 allele for apolipoprotein E. New England Journal of Medicine, 334, 752-758.
40. 12, vitamin B6, folate, homocyteine to cognitive performance in the Normative Aging Study. American Journal of Clinical Nutrition, 63, 306-314.
41. Ritchie, K., Artero, S., & Touchon, J. (2001). Classification criteria for mild cognitive impairment: A population-based validation study. Neurology, 56, 37-42.
42. 12 and folate status on cognitive functioning in very old age. Biological Psychology, 56, 247-265.
43. Satz, P. (1993). Brain reserve capacity on symptom onset after brain injury: A formulation and review of evidence for threshold theory. Neuropsychology, 7, 237-295.
44. Skoog, I. (2000). Detection of preclinical Alzheimer's disease. The New England Journal of Medicine, 343, 502-503.
45. Small, B. J., Basun, H., & Backman, L. (1998). Three-year changes in cognitive performance as a function of apolipoprotein E genotype: Evidence from very old adults without dementia. Psychology and Aging, 13, 80-87.
46. Stern, Y. (2002). What is cognitive reserve? Theory and research application of the reserve concept. Journal of the International Neuropsychological Society, 8, 448-460.
47. 12 and folate status on episodic memory performance in very old age: A population-based study. Psychology and Aging, 11, 487-496.
48. 12 and folate in relation to the development of Alzheimer's disease. Neurology, 56, 1188-1194.
49. Wechsler, D. (1981). WAIS-R: Manual: Wechsler adult intelligence scale-revised. New York: Harcourt Brace Jovanovich.
50. Winnock, M., Letenneur, L., Jacqmin-Gadda, H., Dallongeville, J., Amouyel, P., & Dartigues, J. F. (2002). Longitudinal analysis of the effect of apolipoprotein E e4 and education on cognitive performance in elderly subjects: The PAQUID study. Journal of Neurology, Neurosurgery and Psychiatry, 72, 794-797.
51. Yaffe, K., Haan, M., Byers, A., Tangen, C., & Kuller, L. (2000). Estrogen use, APOE, and cognitive decline: Evidence of gene-environment interaction. Neurology, 54, 1949-1953.